Insider trade

Officer sold ~$67K of LH shares in the open market

Traded Jul 2, 2026 · Filed Jul 6, 2026

LabcorpLH

~$67K
Reported value · 234 sh @ $286.19: 6,745.57
Holds after · shares reported: +6.1%
stock since the trade · S&P 500 +2.6%, $286.98 → $304.60 on Oct 1

Why it stands out

Labcorp's and President, Diagnostics sold $67K of Labcorp shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jul 2, 2026
Reporting period: Not applicable
Filed with the SEC: Jul 6, 2026

Officer$25K–$100KPre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$66,968

Shares × reported transaction price

Timing vs results

63 days after results of Apr 30, 2026, 28 days before results of Jul 30, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $286.98 on Jul 2, 2026, within 2% of its 52-week high, after a 13% rise over the previous 30 trading days

52-week range $243.04 (Jul 21, 2025) to $290.93 (Oct 20, 2025), 92% of the way up, from 251 adjusted closes. 30 trading days earlier: $253.69 on May 19, 2026. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	-2.9%	+0.6%	-3.4%
30 days	+11.5%	+2.8%	+8.7%

Past results only. Not a forecast.

Source receipt

Record ID: 0000920148-26-000151
Filed / recorded: Jul 6, 2026, 1:36 PM UTC
Added to OQRO: Oct 2, 2026, 12:28 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: LABCORP HOLDINGS INC.
Issuer CIK: 920148
Ticker: LH
Reporting person: Bryan T Vaughn
Relationship: Officer
Officer title: EVP and President, Diagnostics
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Jul 2, 2026
Transaction code: S
Shares / units: 234
Price per share: $286.19
Acquired / disposed: Disposed (D)
Shares owned after: 6,745.5702
Ownership form: Direct
Amendment: No

Footnotes from the filing

Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Around the same time

Officer sold2mo ago

~$25KReported value · 82 sh @ $309.22

1,852.22 → 1,770.22 shares held−4% of their stake

Labcorp's SVP, Chief Accounting Officer sold $25K of Labcorp shares. Nobody planned it ahead of time.

Why it stands out Official record

2mo ago

1,338Shares · @ $209.25

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

Officer sold2mo ago

~$414KReported value · 1,338 sh @ $309.2311

3,108.22 → 1,770.22 shares held−43% of their stake

Labcorp's SVP, Chief Accounting Officer sold $414K of Labcorp shares. Nobody planned it ahead of time.

Why it stands out Official record

Why it stands out

Dates, kept separate

Context

After it was reported

Source receipt

Footnotes from the filing

Around the same time

~$25KReported value · 82 sh @ $309.22

1,338Shares · @ $209.25

~$414KReported value · 1,338 sh @ $309.2311

Most active this month